Piper Jaffray Remains on Sidelines with Sarepta (SRPT) Despite Rolling NDA For Eteplirsen

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. SPCX
3. MU
4. SPY
5. ACN
6. IBM
7. PRIM
8. PFE
9. TSLA
10. DPZ

Go back to Piper Jaffray Remains on Sidelines with Sarepta (SRPT) Despite Rolling NDA For Eteplirsen
SAREPTA THERAP (NASDAQ: SRPT) Delayed: 17.50 -0.15 (0.85%)
Previous Close $17.65    52 Week High $63.73 
Open $17.33    52 Week Low $8.00 
Day High $17.80    P/E N/A 
Day Low $17.25    EPS $-5.69 
Volume 789,107